The global chitosan market size was valued at USD 5.51 billion in 2025 and is projected to grow from USD 6.21 billion in 2026 to USD 16.17 billion by 2034, registering a CAGR of 12.71% during the forecast period from 2026 to 2034. Asia Pacific dominated the chitosan market with a market share of 38.7% in 2025.
Chitosan is a natural biopolymer derived from chitin, a substance found in the shells of shrimp, crabs, and other crustaceans. It is biodegradable, biocompatible, and non-toxic, making it widely used in pharmaceuticals, food preservation, water treatment, agriculture, and biomedical applications.
Download a Free Sample To learn more about this report,
Shift Toward Enzymatically Modified Chitosan
Advances in biocatalytic processing are shifting chitosan toward enzymatically modified forms, as enzymes can tailor molecular weight, degree of deacetylation, and functional properties under milder conditions than conventional chemical modification; enzymatic hydrolysis has been shown to produce low-molecular-weight chitosan fractions with improved solubility and application-specific properties.
Development of Chitosan-Based Antimicrobial Food Coatings
The demand for safer methods of extending food shelf life is driving the development of chitosan-based antimicrobial food coatings, with the polymer forming edible films that can limit microbial growth while reducing direct exposure of food to synthetic preservatives; research on chitosan coatings has reported antimicrobial activity against pathogens including Escherichia coli and Listeria monocytogenes on fresh produce.
Expansion of Pharmaceutical and Drug-Delivery Applications and Increasing Use in Wound-Care Products Drive Market
The expansion of pharmaceutical applications increases demand for chitosan because its biocompatibility and mucoadhesive properties support drug-delivery and controlled-release systems. Growing research into oral, nasal, and topical delivery creates additional requirements for chitosan-based formulations. For example, chitosan-based nanoparticles can support the delivery of therapeutic compounds by improving drug retention and controlled release. Wider pharmaceutical use increases procurement of high-purity chitosan and encourages suppliers to develop consistent medical-grade materials. The broader drug-delivery application base therefore supports demand across the chitosan market.
The increasing use of advanced wound-care products creates demand for chitosan because of its biocompatibility, film-forming properties, and ability to support wound-management applications. Growing requirements for dressings and wound-management materials expand the use of chitosan in healthcare products. For example, chitosan-based wound dressings can help manage bleeding and provide a protective matrix over damaged tissue. Higher adoption of these products increases demand for medical-grade chitosan and supports investment in specialized production capacity. The expanding wound-care application base therefore strengthens demand for chitosan materials.
High Production and Processing Costs and Complex Extraction and Purification Processes Restrain Market Expansion
Specialized equipment, controlled processing conditions, purification, drying, and quality testing increase the overall cost of chitosan production. These requirements raise product prices and can reduce cost competitiveness against synthetic and alternative biopolymers. Higher production costs can limit adoption in price-sensitive applications and slow market expansion.
Chitosan production requires multiple processing steps to extract and purify the material from chitin-rich sources while achieving the required degree of deacetylation and purity. Process complexity can increase processing time, energy use, and quality-control requirements, particularly for high-purity grades. These constraints can limit production scalability and delay wider adoption across advanced applications.
Increasing Use in Textile Processing and Expansion of Chitosan in Water Treatment Offer Growth Opportunities
Textile manufacturers can use chitosan for fabric finishing, dyeing, and functional treatments that add antimicrobial or surface-modifying properties. Market players can generate additional revenue through textile-grade chitosan and customized treatment solutions. Textile processors can provide a broader customer base for suppliers developing consistent, application-specific material grades.
Water-treatment operators can use chitosan as a bio-based flocculant for removing suspended solids, metals, and other contaminants. Suppliers can create new revenue through treatment-grade chitosan, customized formulations, and supply contracts with municipal and industrial facilities. Demand from industrial wastewater treatment can broaden the addressable customer base beyond conventional chitosan applications.
Limited Performance Consistency Across Applications and Dependence on Crustacean-Based Feedstock Hinders Growth
Chitosan properties can change significantly with molecular weight and deacetylation levels, meaning a grade suitable for one application may not perform similarly in another. For example, chitosan-based drug-delivery systems require tightly controlled material properties for predictable release behavior, limiting the use of generic grades and slowing broader commercialization.
Heavy reliance on shrimp, crab, and other crustacean shells exposes manufacturers to seasonal availability, geographic concentration, and fluctuations in seafood-processing activity. For example, shrimp-processing disruptions in major producing regions can reduce shell availability, creating supply uncertainty for chitosan producers and limiting continuous production.
The shrimp segment accounted for a share of 41.9% in 2025, owing to its broad availability as a chitin source and established processing supply for chitosan production. The crab segment provides another established crustacean-derived source, while the squid segment supports specialized chitosan production. The krill segment offers an alternative marine source, and the others segment includes additional raw materials used for chitosan extraction.
The krill segment is expected to grow at a CAGR of 18.64% during the forecast period 2026-2034, driven by increasing interest in alternative marine sources for chitosan production. The shrimp and crab segments continue to benefit from established raw-material supply, while squid and other sources serve specialized production requirements.
Request Customizationto receive a tailored report.
The powder segment accounted for a share of 54.2% in 2025, owing to its easy handling, storage, and suitability for formulation across pharmaceutical, food, agricultural, and industrial applications. The solution segment is used where chitosan needs to be incorporated directly into liquid formulations, while the fiber segment supports specialized biomedical and filtration applications. The film segment is used for coatings, packaging, and controlled-release applications.
The fiber segment is expected to grow at a CAGR of 18.87% during the forecast period 2026-2034, driven by increasing use of chitosan fibers in biomedical materials and specialized functional products. The powder segment remains widely applicable across multiple formulations, while solution and film forms serve liquid-based and surface-oriented applications.
The biomedical & pharmaceutical segment accounted for a share of 34.6% in 2025, owing to the use of chitosan in drug delivery, wound care, tissue engineering, and other biomedical applications. The food & beverages segment uses chitosan for preservation and food-processing applications, while the cosmetics segment incorporates it into selected personal care formulations. The agrochemicals segment supports agricultural formulations, and the others segment covers additional industrial applications.
The biomedical & pharmaceutical segment is expected to grow at a CAGR of 19.48% during the forecast period 2026-2034, driven by expanding research into chitosan-based drug delivery, wound treatment, and biomaterial applications. The food & beverages, cosmetics, and agrochemicals segments continue to support demand through their respective formulation and processing uses, while the others segment serves specialized applications.
Speak to an Analystto discuss market opportunities.
The Asia Pacific chitosan market accounted for the largest regional share of 38.7% in 2025, supported by increasing demand for biodegradable and functional materials across healthcare, agriculture, water treatment, food processing, and packaging applications. The region’s expanding industrial and healthcare infrastructure, along with growing interest in bio-based materials, is further supporting chitosan adoption across downstream industries.
The Japan chitosan market is expected to benefit from expanding healthcare demand associated with population aging, with Japan projecting the share of people aged 65 and above to reach 33.3% by 2040 and 38.7% by 2070, while the government’s bioeconomy strategy targets a ¥39.1 trillion bioeconomy market by 2030, supporting opportunities for bio-based materials in healthcare and related applications. The China chitosan market is expected to benefit from growing demand for food and bio-based materials, with China’s 2025–2030 Food and Nutrition Development Plan setting targets for improving nutrition, food processing, and food-quality systems through 2030, creating opportunities for functional and bio-based materials such as chitosan in food and packaging applications.
The South Korea chitosan market is expected to benefit from the government’s shift toward high-value and eco-friendly materials, with the 2026–2030 Basic Plan for the Materials, Parts and Equipment Industry targeting 10 additional specialized clusters by 2030, 15 advanced technology projects, and five AI-based new-material projects, supporting development and adoption of next-generation bio-based materials. The India chitosan market is expected to benefit from the country’s shift toward sustainable packaging, with the Indian government emphasizing the need for sustainable, recyclable, and biodegradable alternatives and expanding stakeholder efforts around sustainable food packaging, creating opportunities for biodegradable materials such as chitosan in packaging applications.
Unlock Regional Insightsto access country-level data, & regional trends.
The North America chitosan market is expected to grow at a CAGR of 19.85% during the forecast period 2026–2034, showcasing the fastest-growing regional market, supported by increasing demand for biodegradable materials across healthcare, water treatment, food, and packaging applications.
The United States chitosan market is expected to benefit from rising healthcare demand associated with population aging, with the U.S. Census Bureau projecting the share of people aged 65 and older to increase from 18.9% in 2025 to 23.4% by 2060, while the National Institute on Aging projects Americans living with Alzheimer’s disease to exceed 13.9 million by 2060, supporting demand for chitosan-based biomaterials and healthcare applications.
The Canada chitosan market is expected to benefit from population aging and expanding healthcare needs, with Statistics Canada projecting the share of people aged 65 and older to increase from 18.5% in 2021 to 23.1% by 2043 and 25.9% by 2068, while the population aged 85 and older is projected to more than triple from 871,000 in 2021 to 3.2 million by 2068, supporting demand for chitosan-based biomaterials and medical applications.
The European chitosan market accounted for a regional share of 21.8% in 2025, supported by increasing demand for biodegradable and bio-based materials across healthcare, agriculture, water treatment, food, and packaging applications.
The UK chitosan market is expected to benefit from population aging and increasing healthcare needs, with the Office for National Statistics projecting the UK population to reach 72.5 million by mid-2054, while the number of people aged 85 and over is projected to increase from 1.7 million in 2024 to 3.3 million by 2049, supporting demand for chitosan-based biomaterials and healthcare applications. The Germany chitosan market is expected to benefit from population aging and associated healthcare demand, with Germany’s Federal Statistical Office projecting one in four people to be aged 67 or older by 2035, while the number of people aged 67 and above is projected to reach 20.1–21.8 million by 2070, supporting demand for chitosan-based biomaterials and medical applications.
The French chitosan market is expected to benefit from population aging, with INSEE projecting the number of people aged 65 and older to increase from 15.3 million in 2026 to 21.1 million by 2070, while the number of people aged 80 and older is expected to rise by 4.6 million to nearly 9 million, supporting demand for chitosan-based biomaterials and healthcare applications.
The chitosan market is moderately fragmented, with participation from biopolymer manufacturers, specialty chemical companies, marine-derived material producers, biotechnology firms, and regional suppliers serving pharmaceutical, food and beverage, agriculture, water treatment, cosmetics, and biomedical applications. The leading players in the global chitosan market are Golden-Shell Pharmaceutical, Advanced Biopolymers AS, Qingdao Yunzhou Biochemistry Co., Ltd., PRIMEX EHF, and Heppe Medical Chitosan GmbH; however, a reliable published cumulative market-share figure for these exact five companies is not publicly disclosed, so it should not be stated without estimation.
Established players compete primarily on product purity, molecular weight and degree of deacetylation, production capacity, quality consistency, and established distribution networks. Emerging and regional players in the chitosan market ecosystem compete through application-specific grades, customized formulations, improved processing technologies, cost-efficient production, and specialized chitosan derivatives designed for targeted end-use requirements.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Head
Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.
His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.
Biological Seed Treatment Market Size, Share, Growth, Analysis, 2034
Bio-Alcohol Market Size, Share, Growth, Analysis, Report, 2034
Chondroitin Sulfate Market Size, Share, Growth, Analysis, 2034
Neem Oil Market Size, Share, Growth, Analysis, Report, 2034
Europe Pine Chemicals Market Size & Trends by 2034
North America Pine Chemicals Market Size & Trends by 2034
We are featured on:
sales@straitsresearch.com